Research ArticleClinical Studies
Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy
MIOKO MATSUO, RYUJI YASUMATSU, MUNEYUKI MASUDA, SATOSHI TOH, TAKAHIRO WAKASAKI, KAZUKI HASHIMOTO, RINA JIROMARU, TOMOMI MANAKO and TAKASHI NAKAGAWA
In Vivo March 2022, 36 (2) 907-917; DOI: https://doi.org/10.21873/invivo.12780